Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALLO - Allogene Therapeutics Inc. (ALLO) CEO David Chang on Q2 2021 Results - Earnings Call Transcript

ALLO - Allogene Therapeutics Inc. (ALLO) CEO David Chang on Q2 2021 Results - Earnings Call Transcript

Allogene Therapeutics Inc.
Allogene Therapeutics, Inc. (ALLO) Q2 2021 Earnings Conference Call August 04, 2021, 05:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and CEO Rafael Amado - EVP, Research and Development and CMO Eric Schmidt - CFO Conference Call Participants Marc Frahm - Cowen & Company Luca Issi - RBC Salveen Richter - Goldman Sachs Jason Gerberry - Bank of America John Newman - Canaccord Mark Breidenbach - Oppenheimer Reni Benjamin - JMP Securities Raju Prasad - William Blair Dane Leone - Raymond James Asthika Goonewardene - Truist Kalpit Patel - B. Riley Securities Presentation Operator Hello, thank you for standing by, and welcome to Allogene Therapeutics Second Quarter 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Christine

For further details see:

Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q2 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Allogene Therapeutics Inc.
Stock Symbol: ALLO
Market: NASDAQ
Website: allogene.com
Menu
ALLO ALLO Quote ALLO Short ALLO News ALLO Articles ALLO Message Board
Get ALLO Alerts

News, Short Squeeze, Breakout and More Instantly...